Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Abzena, Alira Health and Oncodesign Launch DRIVE™-Biologics to Support Access to Specialist Services from Discovery to Clinical Development for Oncology and Inflammation
Abzena, a partner research organization for integrated services from discovery through to clinical and commercial […]
Oncodesign, Covalab, CheMatech and ABX-CRO Launch DRIVE™-MRT, a Premium Complete, Integrated Service Offer for Radiopharmaceuticals Drug Discovery and Generation
ONCODESIGN (ALONC -FR0011766229), a French biopharmaceutical company dedicated to precision medicine, Covalab (Bron, France), a biotechnology company specializing […]
InterSystems and Oncodesign Partner for the Optimization of Data Use to Enhance and Accelerate Drug Discovery Processes in Oncologyery Processes in Oncology
InterSystems, a leader in healthcare data management, and Oncodesign (Paris:ALONC), a biopharmaceutical company specializing in precision medicine, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more